REGN-5713/REGN-5714/REGN-5715

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug NameREGN-5713/REGN-5714/REGN-5715
Drug Alias NameREGN-5713-5714-5715REGN5713-5714-5715
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIgE receptors modulators
TargetsIgE receptors
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A